Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-22-038936

Options or other derivatives

  • Director acquired 23,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SCHAFER CAROL · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-06-21 Grant or award : show line 1 in the form Option to purchase common stock +23,000 $14.84 2032-06-20 23,000 23,000 D
Loading xslF345X03/doc4.xml…